Document Detail


Estimating the date of hepatitis C virus infection from patient interviews and antibody tests on stored sera.
MedLine Citation:
PMID:  15307870     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Studies on the natural history and outcome of chronic hepatitis C virus (HCV) infection differ regarding the proportion of persons who develop serious sequelae over time. Most of these studies use an estimated date of HCV infection based on risk factor data obtained from patient interviews. The date of HCV infection is often estimated using the year of a pre-1992 blood transfusion (BT), or the first year of injecting drug use (IDU). We sought to determine the accuracy of these dates obtained by interview. METHODS: We compared BT dates reported by patients in a long-term HCV outcome study to dates confirmed in a BT-Lookback project, and also compared the reported first year of IDU to seroconversion dates estimated from HCV tests on historical sera. RESULTS: Of 28 BT recipients who were interviewed in the HCV outcome study and identified in the Lookback project, 14 (50%; 95% CI: 31-69%) were unaware they had received a BT. Of 25 persons identified in the BT-Lookback project with historical sera available, 9 (36%; 95% CI: 19-57%) had anti-HCV results that did not correlate with their confirmed BT date. Of 216 persons with a history of IDU and historical serum samples available, 66 (31%; 95% CI: 25-37%) had anti-HCV results that did not correlate with their reported first year of IDU. CONCLUSIONS: Inaccuracies in the length of HCV could occur in outcome studies that rely on patient recall of risk-factor history. Statistical methods that incorporate the uncertainty in assigning infection date are needed.
Authors:
Dana L Bruden; Brian J McMahon; Thomas W Hennessy; Carol J Christensen; Chriss E Homan; James L Williams; Daniel G Sullivan; David R Gretch; Henry H Cagle; Lisa R Bulkow
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The American journal of gastroenterology     Volume:  99     ISSN:  0002-9270     ISO Abbreviation:  Am. J. Gastroenterol.     Publication Date:  2004 Aug 
Date Detail:
Created Date:  2004-08-13     Completed Date:  2004-09-17     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0421030     Medline TA:  Am J Gastroenterol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1517-22     Citation Subset:  IM    
Copyright Information:
Copyright 2004 American College of Gastroenterology
Affiliation:
Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska 99508, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Blood Transfusion / adverse effects
Hepatitis C Antibodies / blood*
Hepatitis C, Chronic / diagnosis,  immunology,  transmission*
Humans
Interviews as Topic
Middle Aged
Substance Abuse, Intravenous / virology
Time Factors
Grant Support
ID/Acronym/Agency:
AI 48214/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
0/Hepatitis C Antibodies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis develo...
Next Document:  HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease...